Single-Dose Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy

Neurol Neuroimmunol Neuroinflamm. 2021 May 26;8(4):e1021. doi: 10.1212/NXI.0000000000001021. Print 2021 Jul.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Female
  • Humans
  • Immunologic Factors / administration & dosage*
  • Leukoencephalopathy, Progressive Multifocal / drug therapy*
  • Male
  • Middle Aged

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunologic Factors
  • pembrolizumab